Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Personalized Cancer Treatment Market Report 2024

Personalized Cancer Treatment Global Market Report 2024 – By Treatment Type (Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type), By Diagnostic Techniques (Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types), By End-Users (Hospitals And Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Personalized Cancer Treatment Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Global Personalized Cancer Treatment Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Personalized Cancer Treatment Market Definition

Personalized cancer treatment customizes therapies based on an individual's unique genetic profile and tumor characteristics, to achieve more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by examining genetic mutations and biomarkers, compared to traditional one-size-fits-all methods.

The main types of personalized cancer treatment include targeted therapy, immunotherapy, hormone therapy, chemotherapy, radiation therapy, and others. Targeted therapy uses drugs or other substances to precisely identify and attack cancer cells without harming normal cells. Diagnostic techniques such as genomic sequencing, liquid biopsy, immunohistochemistry, in situ hybridization, biomarker testing, and other diagnostic techniques are used for cancer types including breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others, and are used by end-users including hospitals and clinics; research institutes; others

Personalized Cancer Treatment Market Segmentation

The personalized cancer treatment market covered in this report is segmented –

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type

2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types

4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Global Personalized Cancer Treatment Market Size 2023 to 2028: Graph

Personalized Cancer Treatment Market Size 2024 And Growth Rate

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $163.95 billion in 2023 to $181.55 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies.

Personalized Cancer Treatment Market Growth Forecast

The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $237.92 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models.

Book your 30 minutes free consultation with our research experts

Contact Us

Personalized Cancer Treatment Market Driver: Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market

The increasing cancer prevalence is expected to propel the growth of the personalized cancer treatment market going forward. The rise in cancer is largely attributed to increasing life expectancy, which leads to more people reaching an age where cancer is more common and growing exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer treatments provide targeted and effective therapies to manage diverse cancer types and stages, and this growing burden stimulates investment and innovation in precision medicine, aiming to improve patient outcomes through customized treatment plans. For instance, in February 2024, according to the World Health Organization, a Switzerland-based United Nations agency dedicated to global health and safety, the global cancer burden is projected to rise significantly, with an anticipated 77% increase in new cancer cases, reaching over 35 million by 2050 compared to 20 million in 2022. Therefore, increasing cancer prevalence is driving the growth of the personalized cancer treatment market.

Global Personalized Cancer Treatment Market Major Players

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

Global Personalized Cancer Treatment Market Trend: AI-Driven Analytics Revolutionizing Personalized Cancer Treatment

Major companies operating in the personalized cancer treatment market are focusing on developing innovative solutions, such as artificial intelligence (AI)-enabled multimodal immune profile algorithmic tests, to predict patient responses to immunotherapy and improve personalized treatment strategies. An AI-enabled multimodal immune profile algorithmic test analyzes multiple types of data, including genomic, transcriptomic, and clinical biomarkers, to assess a patient's immune profile and predict their response to immunotherapy to help stratify patients and guide personalized cancer treatments. For instance, in July 2024, Tempus AI, Inc., a US-based health technology company, launched its AI-enabled multimodal immune profile algorithmic test (IPS), marking its first offering in the immunotherapy diagnostics space. The test, available for research use only (RUO), assesses a range of immunotherapy-related biomarkers to generate a score that helps predict patient response to immunotherapy, supporting personalized cancer treatment. The AI-driven immunotherapy-focused diagnostics enhance patient stratification and treatment selection in oncology.

Personalized Cancer Treatment Market Merger And Acquisition: Pfizer Acquires Seagen To Strengthen Oncology Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to leverage its cutting-edge antibody-drug conjugate technology, enhancing its capabilities in developing targeted cancer therapies. This strategic move aims to accelerate Pfizer's growth in the oncology market, addressing the urgent need for more effective cancer treatments. Seagen Inc. is a US-based biotechnology company focused on developing monoclonal antibody-based therapies for the treatment of cancer.

Regional Insights For The Global Personalized Cancer Treatment Market

North America was the largest region in the personalized cancer treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer treatment market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cancer treatment market consists of revenues earned by entities by providing services such as genetic testing, biomarker analysis, personalized therapy formulation, and targeted drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cancer treatment market also includes sales of products including targeted therapy drugs, genomic profiling kits, and companion diagnostics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The personalized cancer treatment market research report is one of a series of new reports from the business research company that provides personalized cancer treatment market statistics, including personalized cancer treatment industry global market size, regional shares, competitors with an personalized cancer treatment market share, detailed personalized cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer treatment industry. This personalized cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Personalized Cancer Treatment Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $181.55 billion
Revenue Forecast In 2033 $237.92 billion
Growth Rate CAGR of 10.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment Type: Targeted Therapy; Immunotherapy; Hormone Therapy; Chemotherapy; Radiation Therapy; Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing; Liquid Biopsy; Immunohistochemistry; In Situ Hybridization; Biomarker Testing; Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Other Cancer Types
4) By End-Users: Hospitals And Clinics; Research Institutes; Other End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Personalized Cancer Treatment Market Characteristics

    3. Personalized Cancer Treatment Market Trends And Strategies

    4. Personalized Cancer Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Personalized Cancer Treatment Market Size and Growth

    5.1. Global Personalized Cancer Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Personalized Cancer Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Personalized Cancer Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Personalized Cancer Treatment Market Segmentation

    6.1. Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Targeted Therapy

    Immunotherapy

    Hormone Therapy

    Chemotherapy

    Radiation Therapy

    Other Treatment Type

    6.2. Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Genomic Sequencing

    Liquid Biopsy

    Immunohistochemistry

    In Situ Hybridization

    Biomarker Testing

    Other Diagnostic Techniques

    6.3. Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Breast Cancer

    Lung Cancer

    Colorectal Cancer

    Prostate Cancer

    Melanoma

    Other Cancer Types

    6.4. Global Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinics

    Research Institutes

    Other End Users

    7. Personalized Cancer Treatment Market Regional And Country Analysis

    7.1. Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Personalized Cancer Treatment Market

    8.1. Asia-Pacific Personalized Cancer Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Personalized Cancer Treatment Market

    9.1. China Personalized Cancer Treatment Market Overview

    9.2. China Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Personalized Cancer Treatment Market

    10.1. India Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Personalized Cancer Treatment Market

    11.1. Japan Personalized Cancer Treatment Market Overview

    11.2. Japan Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Personalized Cancer Treatment Market

    12.1. Australia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Personalized Cancer Treatment Market

    13.1. Indonesia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Personalized Cancer Treatment Market

    14.1. South Korea Personalized Cancer Treatment Market Overview

    14.2. South Korea Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Personalized Cancer Treatment Market

    15.1. Western Europe Personalized Cancer Treatment Market Overview

    15.2. Western Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Personalized Cancer Treatment Market

    16.1. UK Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Personalized Cancer Treatment Market

    17.1. Germany Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Personalized Cancer Treatment Market

    18.1. France Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Personalized Cancer Treatment Market

    19.1. Italy Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Personalized Cancer Treatment Market

    20.1. Spain Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Personalized Cancer Treatment Market

    21.1. Eastern Europe Personalized Cancer Treatment Market Overview

    21.2. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Personalized Cancer Treatment Market

    22.1. Russia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Personalized Cancer Treatment Market

    23.1. North America Personalized Cancer Treatment Market Overview

    23.2. North America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Personalized Cancer Treatment Market

    24.1. USA Personalized Cancer Treatment Market Overview

    24.2. USA Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Personalized Cancer Treatment Market

    25.1. Canada Personalized Cancer Treatment Market Overview

    25.2. Canada Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Personalized Cancer Treatment Market

    26.1. South America Personalized Cancer Treatment Market Overview

    26.2. South America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Personalized Cancer Treatment Market

    27.1. Brazil Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Personalized Cancer Treatment Market

    28.1. Middle East Personalized Cancer Treatment Market Overview

    28.2. Middle East Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Personalized Cancer Treatment Market

    29.1. Africa Personalized Cancer Treatment Market Overview

    29.2. Africa Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Personalized Cancer Treatment Market Competitive Landscape And Company Profiles

    30.1. Personalized Cancer Treatment Market Competitive Landscape

    30.2. Personalized Cancer Treatment Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bristol Myers Squibb Company

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Personalized Cancer Treatment Market Other Major And Innovative Companies

    31.1. Thermo Fisher Scientific Inc.

    31.2. AstraZeneca Plc

    31.3. Novartis AG

    31.4. BioNTech SE

    31.5. Illumina Inc.

    31.6. Artera

    31.7. Exact Sciences Corporation.

    31.8. Moffitt Cancer Center

    31.9. Myriad Genetics

    31.10. NeoGenomics Laboratories

    31.11. Guardant Health

    31.12. Caris Life Sciences

    31.13. Tempus AI Inc.

    31.14. Foundation Medicine

    31.15. Immatics

    32. Global Personalized Cancer Treatment Market Competitive Benchmarking

    33. Global Personalized Cancer Treatment Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Personalized Cancer Treatment Market

    35. Personalized Cancer Treatment Market Future Outlook and Potential Analysis

    35.1 Personalized Cancer Treatment Market In 2028 - Countries Offering Most New Opportunities

    35.2 Personalized Cancer Treatment Market In 2028 - Segments Offering Most New Opportunities

    35.3 Personalized Cancer Treatment Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Financial Performance
  • Table 77: F. Hoffmann-La Roche Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: Bristol Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Personalized Cancer Treatment Market, Segmentation By End-users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Financial Performance
  • Figure 77: F. Hoffmann-La Roche Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: Bristol Myers Squibb Company Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

Cancer Immunotherapy Global Market Report 2024 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Solid Tumor Cancer Treatment Global Market Report 2024 – By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures), By Application (Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications ), By End-Users (Hospitals, Research Institutes, Homecare) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Endometrial Cancer Treatment Global Market Report 2024 – By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Metastatic Breast Cancer Treatment Global Market Report 2024 – By Therapy Type (Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy), By Molecule Type (Monoclonal Antibody, Peptides, Polymer, Small Molecule, Gene Therapy), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bone Cancer Treatment Global Market Report 2024 – By Type (Multiple Myeloma, Osteosarcoma, Chondrosarcoma, Ewing Sarcoma), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Esophageal Cancer Global Market Report 2024 – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End Users (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Appendiceal Cancer Treatment Global Market Report 2024 – By Type (Colonic-Type Adenocarcinoma, Mucinous Adenocarcinoma Of Appendix, Goblet Cell Adenocarcinoma, Neuroendocrine Carcinoma, Other Types), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Other Treatments), By Route Of Administration (Oral, Intravenous, Other Routes of Administration), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

AI In Cancer Diagnostics Global Market Report 2024 – By Component (Software Solutions, Hardware, Services), By Cancer Type ( Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types), By Application (Screening And Diagnosis, Tumor Identification, Monitoring), By End User (Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the personalized cancer treatment market?

Personalized cancer treatment customizes therapies based on an individual's unique genetic profile and tumor characteristics, to achieve more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by examining genetic mutations and biomarkers, compared to traditional one-size-fits-all methods. For further insights on the personalized cancer treatment market, request a sample here

How will the personalized cancer treatment market drivers and restraints affect the personalized cancer treatment market dynamics? What forces will shape the personalized cancer treatment industry going forward?

The personalized cancer treatment market major growth driver - Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market. For further insights on the personalized cancer treatment market, request a sample here

What is the forecast market size or the forecast market value of the personalized cancer treatment market?

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $163.95 billion in 2023 to $181.55 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies. The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $237.92 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models. For further insights on the personalized cancer treatment market, request a sample here

How is the personalized cancer treatment market segmented?

The personalized cancer treatment market is segmented
1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End UsersFor further insights on the personalized cancer treatment market, request a sample here

Which region has the largest share of the personalized cancer treatment market? What are the other regions covered in the report?

North America was the largest region in the personalized cancer treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the personalized cancer treatment market, request a sample here.

Who are the major players in the personalized cancer treatment market?

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma For further insights on the personalized cancer treatment market, request a sample here.

What are the key trends in the personalized cancer treatment market?

Major trend in the personalized cancer treatment market - AI-Driven Analytics Revolutionizing Personalized Cancer Treatment. For further insights on the personalized cancer treatment market, request a sample here.

What are the major opportunities in the personalized cancer treatment market? What are the strategies for the personalized cancer treatment market?

For detailed insights on the major opportunities and strategies in the personalized cancer treatment market, request a sample here.

How does the personalized cancer treatment market relate to the overall economy and other similar markets?

For detailed insights on personalized cancer treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the personalized cancer treatment industry?

For detailed insights on the mergers and acquisitions in the personalized cancer treatment industry, request a sample here.

What are the key dynamics influencing the personalized cancer treatment market growth? SWOT analysis of the personalized cancer treatment market.

For detailed insights on the key dynamics influencing the personalized cancer treatment market growth and SWOT analysis of the personalized cancer treatment industry, request a sample here.